Free Trial

Shoulder Innov (NYSE:SI) Director Geoffrey B. Pardo Purchases 100,000 Shares

Shoulder Innovations logo with Medical background

Key Points

  • Director Geoffrey B. Pardo of Shoulder Innovations Inc purchased 100,000 shares at an average price of $15.00 per share, totaling $1.5 million, increasing his stake by 4.39%.
  • The company's stock traded down 0.6%, reaching $14.18 per share, with a market capitalization of $448.92 million.
  • Shoulder Innovations is focused on transforming the shoulder surgical care market with advanced implant systems designed to enhance surgical efficiency and care quality.
  • Looking to Export and Analyze Shoulder Innovations Data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Shoulder Innov (NYSE:SI - Get Free Report) Director Geoffrey B. Pardo acquired 100,000 shares of the stock in a transaction dated Friday, August 1st. The shares were bought at an average price of $15.00 per share, for a total transaction of $1,500,000.00. Following the transaction, the director owned 2,380,482 shares in the company, valued at approximately $35,707,230. This represents a 4.39% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Shoulder Innov Stock Down 7.7%

Shares of NYSE SI traded down $1.00 during mid-day trading on Thursday, hitting $12.06. The stock had a trading volume of 120,375 shares, compared to its average volume of 277,624. Shoulder Innov has a 1 year low of $12.00 and a 1 year high of $17.94.

Shoulder Innov Company Profile

(Get Free Report)

We are a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. We currently offer advanced implant systems for shoulder arthroplasty. These systems are a core element of our ecosystem, which we designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain.

Featured Articles

Should You Invest $1,000 in Shoulder Innovations Right Now?

Before you consider Shoulder Innovations, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Shoulder Innovations wasn't on the list.

While Shoulder Innovations currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without
Palantir & AMD Earnings: Massive Options Setups Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines